We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00005655
First Posted: May 5, 2000
Last Update Posted: October 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Institutes of Health Clinical Center (CC)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2, 2017
  Primary Completion Date: October 6, 2010 (Final data collection date for primary outcome measure)